(Q46979381)

27 December 2017

title

Risk of T2DM and impaired fasting glucose among PCOS subjects: results of an 8-year follow-up (English)

1 reference

27 December 2017

author

Evelyn O. Talbott

2

1 reference

27 December 2017

Maria M. Brooks

4

1 reference

27 December 2017

author name string

Monique Y Boudreaux

1

1 reference

27 December 2017

Kevin E Kip

3

1 reference

27 December 2017

Selma F Witchel

5

1 reference

27 December 2017

publication date

1 February 2006

1 reference

27 December 2017

number of pages

7

1 reference

inferred from page(s)

published in

Current diabetes report

1 reference

27 December 2017

volume

6

1 reference

27 December 2017

issue

1

1 reference

27 December 2017

page(s)

77-83

1 reference

27 December 2017

https://scigraph.springernature.com/pub.10.1007/s11892-006-0056-1

exact match

0 references

cites work

Coronary heart disease risk factors in women with polycystic ovary syndrome.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11892-006-0056-1

Induction of plasminogen activator inhibitor type-1 (PAI-1) by proinsulin and insulin in vivo.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11892-006-0056-1

Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11892-006-0056-1

Quantitative determination of serum triglycerides by the use of enzymes

21 January 2018

1 reference

12 December 2020

Insulin resistance in nonobese patients with polycystic ovarian disease

1 reference

12 December 2020

A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol

1 reference

12 December 2020

Insulin secretion in obese and non-obese women with polycystic ovary syndrome and its relationship with hyperandrogenism

1 reference

12 December 2020

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

12 December 2020

Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome.

1 reference

12 December 2020

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

1 reference

12 December 2020

Ability of Alternative Indices of Insulin Sensitivity to Predict Cardiovascular Risk

1 reference

12 December 2020

Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries

1 reference

12 December 2020

Increased cytochrome P450 17alpha-hydroxylase promoter function in theca cells isolated from patients with polycystic ovary syndrome involves nuclear factor-1.

1 reference

12 December 2020

Dysregulation of cytochrome P450 17alpha-hydroxylase messenger ribonucleic acid stability in theca cells isolated from women with polycystic ovary syndrome

1 reference

12 December 2020

Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women

1 reference

12 December 2020

Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome.

1 reference

12 December 2020

Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in Asian women with polycystic ovary syndrome

1 reference

12 December 2020

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

12 December 2020

Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome

1 reference

12 December 2020

Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study

1 reference

12 December 2020

The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome.

1 reference

12 December 2020

Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women

1 reference

12 December 2020

The prevalence and features of the polycystic ovary syndrome in an unselected population

1 reference

12 December 2020

Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

1 reference

12 December 2020

Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus

1 reference

12 December 2020

Managing type 2 diabetes mellitus in patients with obesity

1 reference

12 December 2020

Insulin resistance in polycystic ovary syndrome.

1 reference

12 December 2020

Evaluation of glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides in the hexokinase method for determining glucose in serum.

1 reference

12 December 2020

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

1 reference

12 December 2020

Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease

1 reference

12 December 2020

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

1 reference

12 December 2020

Do women with polycystic ovary syndrome have an increased risk of cardiovascular disease? Review of the evidence.

1 reference

12 December 2020

Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia

1 reference

12 December 2020

The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome

1 reference

12 December 2020

Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome

1 reference

12 December 2020

Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity.

1 reference

12 December 2020

The Cardiovascular Health Study: design and rationale

1 reference

12 December 2020

Polycystic Ovary Syndrome

1 reference

12 December 2020

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

12 December 2020

10.1007/S11892-006-0056-1

Identifiers

DOI

1 reference

27 December 2017

PubMed ID

16522285

1 reference

27 December 2017